4th Quarter - Report

TIBER CREEK GROUP for AMGEN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1695, Biologics Price Competition and Innovation Act of 2007.

LobbyistCovered position, as disclosed
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar

Contacted: SENATE

Bills named: S. 1695 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.